Locations:
SearchAdvertisement
Undetectable levels achieved for nearly nine months in phase 1 trial
Observational study supports adding CAC score to traditional risk factors for precision medicine approach
Results inform dose selection for further trials of the aldosterone synthase inhibitor
Rates of CR eligibility high and internet access low among older patients in rural areas
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Robust reductions in cardiac events seen in high-risk patients without prior events
Retrospective findings from an executive health program spur interest in broader studies
Inflammation found more predictive of events than LDL-C in pooled analysis of RCTs
Findings bolster the oral drug as an option for primary and secondary prevention
Human and animal studies show a rise in platelet reactivity, thrombosis and cardiac events
Cleveland Clinic leads pioneering assessment of the AI model for health information purposes
Advertisement
Advertisement